Loading…
IBA has signed a Memorandum of Understanding with the University of Pennsylvania Health System for the installation of two ProteusONE compact proton therapy solutions at Penn Presbyterian Medical Center in Philadelphia. The final contract is expected later in 2024, with patient treatments expected to start in 2027.